Adenomatous Polyposis

·MeSH: Adenomatous Polyposis Coli

4 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
cpp-1x/sulindac	SUCAMPO PHARMACEUTICALS, INC. (SCMP)
flynpovi	PANBELA THERAPEUTICS, INC. (SNBP)

Preclinical(1)

Drug	Company
zkn-013	Eloxx Pharmaceuticals, Inc. (ELOXD)

Phase 1/Phase 2(1)

Drug	Company
REC-4881	RECURSION PHARMACEUTICALS, INC. (RXRX)

BioSniper tracks 4 drugs in development for Adenomatous Polyposis across 4 companies.

There are 1 clinical trial targeting Adenomatous Polyposis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.